Discover 3,097 paid clinical trials in Worcester, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,097
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
for
Infusion Reactions
Location: Boston MA, Lake Success NY, New Hyde Park NY,
Sponsor: New York Blood Center
Sex: All
Age: 0+
Code: NCT01656603
Phase2, Recruiting
The PREDICT Registry:
for
DCIS, Stage 0 Breast Cancer, Ductal Breast Carcinoma In Situ
Location: Boston MA, Mineola NY, Lake Success NY, New York NY,
Sponsor: PreludeDx
Sex: Female
Age: 30 - 70+
Code: NCT03448926
Recruiting
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
for
Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma,
Location: Boston MA, New Haven CT, Shirley NY, New York NY,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06324357
Phase1, Phase2, Recruiting
Proton or Photon RT for Retroperitoneal Sarcomas
for
Retroperitoneal Sarcoma
Location: Boston MA, Buffalo NY, Durham NC, Chicago IL,
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT01659203
Phase1, Phase2, Recruiting
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
for
B-cell Acute Lymphoblastic Leukemia,
Location: Boston MA, New Haven CT, Valhalla NY, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 25
Code: NCT06395103
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Boston MA, Stoneham MA, Lebanon NH, Glens Falls NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04269902
Phase3, Recruiting
A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors
for
Sexual Dysfunction, Stem Cell Transplant Complications,
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT06541002
Recruiting
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
for
Childhood Medulloblastoma
Location: Boston MA, Providence RI, Hartford CT, New Haven CT,
Sponsor: Children's Oncology Group
Sex: All
Age: 4 - 21
Code: NCT05382338
Phase3, Recruiting
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
for
Severe Combined Immunodeficiency, X Linked, Gene Therapy
Location: Boston MA, Cincinnati OH, Atlanta GA, Los Angeles CA
Sponsor: David Williams
Sex: Male
Age: 0 - 5
Code: NCT03311503
Phase1, Phase2, Recruiting
Multicenter Evaluation of Near Vision and Outdoor Time in Kids Study
for
Myopia
Location: Boston MA
Sponsor: The University of New South Wales
Sex: All
Age: 4 - 14
Code: NCT06119243
Recruiting
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
for
Lymphatic Malformations
Location: Boston MA, Philadelphia PA, Washington D.C. DC,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 0 - 70+
Code: NCT05948943
Phase2, Phase3, Recruiting
Effect of Theophylline in Pseudohypoparathyroidism
for
PHP Ia, PHP IB, Php1C
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 5 - 21
Code: NCT03718403
Recruiting
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
for
Locally Advanced Solid Tumor
Location: Boston MA, New York NY, Fairfax VA, Detroit MI,
Sponsor: Tango Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05732831
Phase1, Phase2, Recruiting
Featured
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
for
Atopic Dermatitis
Location: Boston MA, Quincy MA, New Haven CT, Lebanon NH,
Sponsor: AbbVie
Sex: All
Age: 18 - 63
Code: NCT06389136
Phase3, Recruiting
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
for
Prostate Cancer (Adenocarcinoma),
Location: Boston MA, Baltimore MD, Myrtle Beach SC,